- IAEA Meetings and Conferences
- Meetings in 2012
- Meetings in 2011
- Past Meetings:
- Meetings in 2010
- Meetings in 2009
- Meetings in 2008
- Meetings in 2007
- Meetings in 2006 Meetings in 2005 Meetings in 2004
- IAEA Meeting Schedule
- Search Meeting Announcements:
- Guide to the VIC:
General Information
Vienna Information
Vienna Sightseeing
Meetings in 2003
27-29 April 2009
Organized by the
Cosponsored by the
In cooperation with the
ANNOUNCEMENT AND CALL FOR PAPERS
The objective of the IAEA programme in Human Health is to enhance the capabilities in Member States to address needs related to the prevention, diagnosis and treatment of health problems through the application of nuclear techniques. The mandate arises from Article II of the IAEA s Statute: “the Agency shall accelerate and enlarge the contribution of atomic energy to health, peace and prosperity throughout the world”. Increased knowledge and technological achievements in the last decades in the clinical, physical and biological aspects of radiation oncology represent important steps in providing tools for effective and safe cancer treatment. These steps include the transition from two-dimensional (2-D) to three dimensional (3-D) treatment planning and delivery including IMRT, the development of functional imaging as compared to classical morphologic imaging and the introduction of advanced molecular biology techniques. Technological innovations are often accepted at face value without a thorough analysis of benefits versus pitfalls. Innovative treatment strategies have established themselves as standard without the scientific evidence to support their superiority as compared with previously existing approaches. Controversy exists in the medical literature over the widespread use of some technologies. The motivations of medical centres to implement some forms of imaging and treatment delivery are usually a combination of industry advertisement, enthusiasm for novel technologies and competitive challenge. However, the hard-data outcomes in terms of local cancer control, improvement of the therapeutic index, long-term survival and ultimate cure may be less compelling. Low and middle income countries with limited public health resources should assess carefully whether the implementation of advanced technologies will reflect in the fulfillment of national priorities in terms of cancer prevention and control. 2. OBJECTIVE The major theme of the ICARO meeting is to review technological advances in radiation oncology and its application in routine clinical practice, especially in mid- and low-income countries. A major goal of the conference will be to educate clinicians on the challenges of new technology in terms of assessing cost benefits, staffing, education, and Quality Assurance (QA), as these issues are frequently not properly considered when decisions are made to purchase new technologies. The main objectives of the conference are: • To exchange information on the current advances in the field among leading experts; This conference will be of interest to individuals involved in the application of new technologies in radiation oncology. In particular, the conference will attempt to put technological developments into the perspective of the priorities of low and middle-income countries. 4. TOPICS The Conference will cover recent developments in the field of radiation oncology. The IAEA welcomes both academic and practice based contributions on the following topics:
5. PAPERS AND POSTERS Concise papers on issues falling within the topics outlined in the section above may be submitted as contributions to the conference. All papers, apart from invited papers, must present original work; they should not have been published elsewhere. (a) Submission of extended synopses Persons interested in presenting a paper or poster at the conference must submit an extended synopsis in English, of not more than 800 words. This should consist of not more than two A4 format pages of single spaced typing, including tables or diagrams and up to three pertinent references. The completed Form for Submission of a Paper (Form B) and the Participation Form (Form A) to the competent national authority for official transmission to the IAEA in time for them to be received by the IAEA before 15 October 2008. In addition, the synopsis should be sent electronically to the Scientific Secretariat, email: ICARO@iaea.org. Authors are urged to make use of the Extended Synopsis Template in Word 2000 on the conference web page. The specifications and instructions for preparing the synopsis and how to use the synopsis template are given in the attached “Instructions on How to Prepare the Synopsis and submit it electronically”. Also attached to this announcement is a sample extended synopsis. The synopsis will be considered only if the Participation Form A and Paper Submission Form B have been received by the IAEA through the official governmental channels or one of the co-sponsoring or cooperating organizations. (b) Acceptance of papers/posters Authors will be informed by the end of December 2008 whether their paper has been accepted by the Programme Committee on the basis of the synopsis submitted. At the same time authors will be advised if their paper has been accepted for oral presentation or for presentation as a poster. However, all of the accepted synopses will be reproduced in unedited form in the “Book of Extended Synopses” which will be distributed to all participants at registration. (c) Proceedings It is intended to prepare a final document including conclusions and recommendations for publication in an international peer-reviewed journal following the meeting. 6. PARTICIPATION All persons wishing to participate in the symposium are requested to register in advance online. In addition they must send a completed Participation Form (Form A) to the competent official authority (Ministry of Foreign Affairs or national atomic energy authority) or one of the co-sponsoring or cooperating organizations for subsequent transmission to the IAEA. A participant will be accepted only if the Participation Form is transmitted through the competent official authority of an IAEA Member State or by an organization invited to participate. Participants whose official nomination has been received by the IAEA will receive further information on the conference approximately two to three months before the meeting. This information will also be posted on the conference web page: http://www-pub.iaea.org/MTCD/Meetings/Announcements.asp?ConfID=35265 7. EXPENDITURES No registration fee is charged to participants. As a general rule, the IAEA does not pay for participants’ travel and living expenses. However, limited funds are available to help meet the cost of attendance of selected specialists, mainly those from developing countries with low economic resources. Generally, not more than one travel grant may be awarded to any one country. If governments wish to apply for a grant on behalf of one of their specialists, they should address specific requests to the IAEA to this effect. Governments should ensure that applications for grants: (a) be submitted before 15 October 2008, (b) be accompanied by a duly completed and signed Grant Application Form (see attached Form C). Applications that do not comply with the conditions mentioned under (a) and (b) cannot be considered. The grants will be lump sums usually covering only part of the cost of attendance. 8. EXHIBITION A limited amount of space will be available for commercial vendors’ displays/exhibits during the conference. Interested parties should contact the Scientific Secretariat. 9. WORKING LANGUAGE 10. DISTRIBUTION OF DOCUMENTS A preliminary programme of the conference will be sent to participants before the meeting. 11. ACCOMMODATION Detailed information on accommodation and other items will be sent directly to all designated participants approximately two to three months before the meeting. This information will also be made available on the conference web page as soon as possible. 12. VISA Designated participants who require a visa to enter Austria should submit the necessary application to the nearest diplomatic or consular representative of Austria as soon as possible. Please note that Austria is a Schengen State and therefore persons who require a visa will have to apply for a ‘Schengen visa’ at least 14 days before entry into Austria. In States where Austria has no diplomatic mission, visas can be obtained from the consular authority of a Schengen Partner State representing Austria in the country in question. At present the Schengen States are: Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain and Sweden. 13. CHANNELS OF COMMUNICATION The Participation Form (Form A), the Form for Submission of a Paper (Form B), together with a copy of each synopsis, and, if applicable, the Grant Application Form (Form C), should be sent to the competent official authority (Ministry of Foreign Affairs or National Atomic Energy Authority) or to one of the co-sponsoring or cooperating organizations for transmission to the IAEA. For possible questions please see contacts below. Subsequent correspondence on scientific matters should be sent to the Scientific Secretary and correspondence on administrative matters to the IAEA Conference Services Section. 14. CONFERENCE WEB PAGE Please visit the IAEA conference web page regularly for new information regarding this conference: 15. CONFERENCE SECRETARIAT Conference Scientific Secretary: Ms. Eeva Salminen Email address for paper submission: ICARO@iaea.org Administration and Organization Ms. Martina Khaelss Commercial Exhibitions Ms. Myriam Obauer-de Bruyker,
|
